Search Results

You are looking at 141 - 150 of 201 items for :

  • "lymph node dissection" x
  • Refine by Access: All x
Clear All
Full access

Mathias Kvist Mejdahl, Birgitte Goldschmidt Mertz, Pernille Envold Bidstrup, and Kenneth Geving Andersen

, 35 receiving surgery with mastectomy or breast-conserving surgery (BCS), and sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) of levels I through II. Adjuvant treatment was according to risk profile, with chemotherapy

Full access

Rofieda R. Alwaqfi, Megan I. Samuelson, Natalya N. Guseva, Michelle Ouyang, Aaron D. Bossler, and Deqin Ma

necrotic hepatic metastases (arrows) 2 months post pazopanib therapy. The patient underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy, lymph node dissection, staging biopsies, and omentectomy and achieved optimal cytoreduction

Full access

Jennifer L. Schwartz, Sandra L. Wong, Scott A. McLean, James A. Hayman, Christopher D. Lao, Jeffrey H. Kozlow, Kelly M. Malloy, Carol R. Bradford, Marcus L. Frohm, Douglas R. Fullen, Lori Lowe, and Christopher K. Bichakjian

angiolymphatic invasion, observation only is recommended at UM. For SLN-positive patients, lymph node dissection (LND) is the preferred treatment, although the optimal treatment for these patients is currently unknown. 31 LND is the most common initial treatment

Full access

Christopher J. Long, Sameer Mittal, and Thomas F. Kolon

. Another technical concern regarding PN that is not present with RN is the role of surgical margins. It is imperative that intraoperative margins are negative from the tumor resection bed. A lymph node dissection is imperative, as with any approach to tumor

Full access

David J. Worhunsky, Yifei Ma, Yulia Zak, George A. Poultsides, Jeffrey A. Norton, Kim F. Rhoads, and Brendan C. Visser

Although multiple quality indicators have been studied for the management of gastric cancer, notably surgical technique and the extent of lymph node dissection, 12 – 14 limited data exist regarding implementation and effectiveness of clinical guidelines

Full access

Fei Gao, Nan Li, YongMei Xu, and GuoWang Yang

prone to local recurrence and distant metastasis after surgery. 2 Multidisciplinary sequential therapy is applied in patients with stage IIIA NSCLC. Complete surgical resection of the primary lesion and mediastinal lymph node dissection are recommended

Full access

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam Chang, Tracy M. Downs, Jason A. Efstathiou, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman-Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Jonathan Tward, Jonathan L. Wright, Lisa A. Gurski, and Alyse Johnson-Chilla

surgery (biopsy or TURBT), and imaging studies. A modifier “p” would refer to pathologic staging based on cystectomy and lymph node dissection. Pathology and Staging The most commonly used staging system is the tumor, node, metastasis (TNM) staging system

Full access

Derek J. Erstad, Mariela Blum, Jeannelyn S. Estrella, Prajnan Das, Bruce D. Minsky, Jaffer A. Ajani, Paul F. Mansfield, Naruhiko Ikoma, and Brian D. Badgwell

; 11 : 439 – 449 . 20409751 10.1016/S1470-2045(10)70070-X 6. Seevaratnam R , Bocicariu A , Cardoso R , A meta-analysis of D1 versus D2 lymph node dissection . Gastric Cancer 2012 ; 15 ( Suppl 1 ): S60 – 69 . 10.1007/s10120

Full access

Andrea Maurichi, Rosalba Miceli, Roberto Patuzzo, Francesco Barretta, Gianfranco Gallino, Ilaria Mattavelli, Consuelo Barbieri, Andrea Leva, Umberto Cortinovis, Elena Tolomio, Milena Sant, Gianpiero Castelli, Leonardo Zichichi, Giovanni Pellacani, Ignazio Stanganelli, Marco Simonacci, Ausilia Manganoni, Corrado Del Forno, Gioachino Caresana, Catherine Harwood, Daniele Bergamaschi, Konstantinos Lasithiotakis, Dorothy Bennett, Vittoria Espeli, Cristina Mangas, Sandra Leoni Parvex, Barbara Valeri, Mara Cossa, Marta Barisella, Alessandro Pellegrinelli, Claudia Miranda, Andrea Anichini, Roberta Mortarini, Odysseas Zoras, and Mario Santinami

completion lymph node dissection (CLND) as additional therapy. Statistical Methods Clinicopathologic characteristics were recorded according to SNB (performed vs not performed) for the whole series of patients, according to SN status (positive vs negative) in

Full access

Linda A. Jacobs and David J. Vaughn

the most commonly used treatment regimens. At the completion of treatment, an assessment of response and the need for postchemotherapy surgery (e.g., a retroperitoneal lymph node dissection [RPLND]) is assessed. Radiation therapy is another treatment